Attached files

file filename
EX-99.1 - PRESS RELEASE - Covidien plccov-2013032913xexx991.htm


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 

FORM 8-K
 
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): March 29, 2013


COVIDIEN PUBLIC LIMITED COMPANY
(Exact Name of Registrant as Specified in Charter)
 
 

 
 
 
 
 
 
Ireland
 
001-33259
 
98-0624794
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of Principal Executive Offices, including Zip Code)
+353 (1) 438-1700
(Registrant's telephone number, including area code)
 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 






Item 7.01.
Regulation FD Disclosure.
On March 29, 2013, Covidien plc (the “Company”) issued a press release announcing that it has won a patent infringement suit. A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 9.01.
Financial Statements and Exhibits.
(d)    Exhibits
99.1    Press Release dated March 29, 2013





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
COVIDIEN PUBLIC LIMITED COMPANY
 
 
By:
 
/s/ John W. Kapples
 
 
John W. Kapples
 
 
Vice President and Corporate Secretary
Date: March 29, 2013





EXHIBIT INDEX

Exhibit No.
 
Exhibit Name

 
 
 
 
99.1
 
Press Release dated March 29, 2013